Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol
about
Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 proteinStructural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptorCrystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptideRecycling of the urokinase receptor upon internalization of the uPA:serpin complexesComplexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptorDirect binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activityA novel endothelial-specific membrane protein is a marker of cell-cell contactsStructural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamilySoluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of ViewsuPAR as a prognostic biomarker in sepsisVEGF-initiated angiogenesis and the uPA/uPAR systemSingle amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasionStructure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor: IMPLICATION FOR PRECLINICAL CANCER THERAPYMyosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.Mapping the topographic epitope landscape on the urokinase plasminogen activator receptor (uPAR) by surface plasmon resonance and X-ray crystallographyNumber and brightness image analysis reveals ATF-induced dimerization kinetics of uPAR in the cell membraneRetro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus.A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors.A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.Urokinase plasminogen activator receptor: Prognostic biomarker for endometrial cancer.Tumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.The plasminogen activator/plasmin systemNew approaches to sepsis: molecular diagnostics and biomarkers.Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastaseImproved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studies.Conformational regulation of urokinase receptor function: impact of receptor occupancy and epitope-mapped monoclonal antibodies on lamellipodia induction.Urokinase type plasminogen activator receptor expression in colorectal neoplasms.Soluble urokinase-type plasminogen activator receptor levels in patients with schizophreniaC-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif.Mimicry of the regulatory role of urokinase in lamellipodia formation by introduction of a non-native interdomain disulfide bond in its receptor.High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.Regulation of u-PAR gene expression by H2A.Z is modulated by the MEK-ERK/AP-1 pathway.Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology.Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissueTransgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.
P2860
Q24293224-641A02A4-0512-4223-BA8B-DAAABA1D3054Q24315974-1CD61D43-A309-4426-A963-40EAF7B78E5AQ24529128-A98C9582-C932-42E6-9AAE-6EC332A8471CQ24532196-70D44A29-36AF-4A59-933A-71837F68A9FDQ24564351-3625DCCC-EA83-4BC4-B32B-0252F53EA83BQ24633333-EB34AC36-36CB-4F27-B554-328387E1A839Q24642987-AE79DE0C-8855-4705-9A4E-5EB8EA52579AQ24672686-90FAA546-8A0F-4AD0-B187-29EF557E4892Q26738374-76086837-7DA1-4F1A-A210-22BDA0F59304Q26858996-AA7F5EFB-C725-4F6E-AC1C-555EE1677311Q27025897-2CEBF115-FE9F-4210-912B-D28F096A9EE5Q27319474-A272C74D-8F20-489B-9F38-59463BC22B67Q27659603-89D93596-BA00-4EF5-B656-735201B700D0Q30304130-01E420DC-57FC-4FAF-9409-E73B55DA7B6CQ30380709-3BCD905B-12A3-4B9C-900E-FCE87D32C294Q30503536-ABA36DE2-2C92-4BDA-ADAF-B32469F7B255Q33683537-A04ACA8E-5541-450F-BECB-953516BD1AADQ33709060-9B1C0BEB-5F2E-4A19-976C-77F99787B8B6Q33741426-D88776CE-8B4F-43D2-A55C-6267369555ACQ33887878-FF18D90F-27FF-47EB-8DAA-9255C6F1A316Q33895912-C163D900-A854-4C00-88DA-2016BA68EA8BQ33907027-6B4BA5FD-F215-4C6C-80CF-C36912F12C3DQ33953134-A9656284-58CC-4F5A-B6C7-AAC4EFD46430Q34075406-3C5D2F7C-71C9-49C6-966C-1B734CF0A5EFQ34089936-F6400BD2-F775-4BC9-B8C3-9926432CA43FQ34202297-9A0E2511-CF66-4597-BE67-8C1E46DD232AQ34303687-AA5FA61E-E41A-4F18-A7C4-BDAA7FB2E428Q34330943-32BDBDC8-1F56-4443-B12E-3C2C1FB9784CQ34992753-B49F725F-1A9F-4CE1-99E4-248EFCCEBBC3Q35312973-F3674049-1242-4528-AAB0-3DF3E8656870Q35353534-9E4F68A4-F149-4A9E-B7A7-70199A400B40Q35369617-E940823D-5A02-4219-9C3E-C6C2EFC3132AQ35562726-A32A0F84-9B23-4B41-BBB7-ED623800B13FQ35604600-EADE4E5C-8F4D-4015-9C70-72F9D9A06EA5Q35617966-5B15159C-82CF-4111-AE2F-F098ECB505CCQ35621562-77438B07-CA77-4D87-969C-617B6CBA4F75Q35672193-0AA02E04-2884-4BE0-84C9-ED6AFB0210BEQ35745789-3D47FF71-E185-4BAB-AC2E-BE3308BD0DF0Q35764327-7FBBDA68-183A-4B2B-8A99-9E34D8E839F4Q35791732-7C15825E-BBE7-43F3-8AE7-6483B964BB9A
P2860
Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol
description
1991 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հունվարին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1991
@ast
im Januar 1991 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1991/01/25)
@sk
vědecký článek publikovaný v roce 1991
@cs
wetenschappelijk artikel (gepubliceerd op 1991/01/25)
@nl
наукова стаття, опублікована в січні 1991
@uk
name
Cellular receptor for urokinas ...... glycosyl-phosphatidylinositol
@ast
Cellular receptor for urokinas ...... glycosyl-phosphatidylinositol
@en
Cellular receptor for urokinas ...... glycosyl-phosphatidylinositol
@nl
type
label
Cellular receptor for urokinas ...... glycosyl-phosphatidylinositol
@ast
Cellular receptor for urokinas ...... glycosyl-phosphatidylinositol
@en
Cellular receptor for urokinas ...... glycosyl-phosphatidylinositol
@nl
prefLabel
Cellular receptor for urokinas ...... glycosyl-phosphatidylinositol
@ast
Cellular receptor for urokinas ...... glycosyl-phosphatidylinositol
@en
Cellular receptor for urokinas ...... glycosyl-phosphatidylinositol
@nl
P2093
P3181
P1476
Cellular receptor for urokinas ...... glycosyl-phosphatidylinositol
@en
P2093
P304
P3181
P407
P577
1991-01-25T00:00:00Z